Analytical Data
-
基因名
PA2G4
- Application
-
别名
EBP1; HG4-1; p38-2G4; Cell cycle protein p38-2G4 homolog; ErbB3-binding protein 1
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UQ80
-
表达区间
Ser2~Asp394
-
分子量
47kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PA2G4, also known as p53-activated gene 4, is a protein that has garnered attention in the field of molecular biology due to its involvement in various cellular processes, including cell proliferation, differentiation, and apoptosis. Initially identified as a transcriptional regulator associated with the p53 tumor suppressor pathway, PA2G4 has been implicated in several types of cancer, as its expression levels can influence tumor growth and progression. Research has shown that PA2G4 interacts with other key cellular proteins and inhibits the activity of cyclin-dependent kinases, thereby playing a critical role in cell cycle regulation. Furthermore, its potential as a biomarker for cancer prognosis has spurred interest in understanding its functional mechanisms at the molecular level. Studies on PA2G4 also suggest its participation in the modulation of immune responses and its potential therapeutic implications in oncology. The recombinant production of PA2G4 provides valuable material for biochemical assays and structural studies, which can further elucidate its role in disease mechanisms and facilitate the development of targeted therapies. As a result, PA2G4 is a subject of ongoing research aimed at unraveling its complex biology and exploring its utility in clinical applications.
